DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia
Humberto J. Ferreira(University of Bonn), Manel Esteller(Institució Catalana de Recerca i Estudis Avançats), Anna Martínez‐Cardús(Institut d'Investigació Biomédica de Bellvitge), Sebastián Morán(Institut d'Investigació Biomédica de Bellvitge), Antonio Gómez(Universitat de Vic - Universitat Central de Catalunya), Miguel Vizoso(Institut d'Investigació Biomédica de Bellvitge), Holger Heyn(Scope Group (United States)), Cátia Moutinho(Bellvitge University Hospital), Laia Simó‐Riudalbas(Bellvitge University Hospital), Enrique Vidal(Leitat Technological Center), Edgar Jost(Universitätsklinikum Aachen)
Cited by 64
Related Papers
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
|Cell|2018|2.4k
A Landscape of Pharmacogenomic Interactions in Cancer
|Cell|2016|2.3k
Inactivation of the DNA-Repair Gene<i>MGMT</i>and the Clinical Response of Gliomas to Alkylating Agents
|New England Journal of Medicine|2000|2.2k
The role of histone deacetylases (HDACs) in human cancer
|Molecular Oncology|2007|984
Toward understanding and exploiting tumor heterogeneity
|Nature Medicine|2015|770